4D Molecular Therapeutics, Inc. (FDMT) Reports FY Loss of $2.58
Tweet
Share
E-mailGet Alerts FDMT Hot Sheet
Join SI Premium – FREE
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported FY EPS of ($2.58).
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Upgrades 4D Molecular Therapeutics (FDMT) to Overweight
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
